Get the Stockscreener App
0.239
3.86%
-0.0096
After Hours:
.25
0.011
+4.60%
Cognition Therapeutics Inc Stock (CGTX) Forecast
The Cognition Therapeutics Inc (CGTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.5436, representing a +1,801% increase from the current price of $0.239. The highest analyst price target is $5.0068, and the lowest is $4.0805.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CGTX Price Target
Average 3.4963
(+1,363% Upside)
Is Cognition Therapeutics Inc (CGTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.50 | Buy |
| STOCH(9,6) | 20.05 | Neutral |
| STOCHRSI(14) | 1.9126 | Buy |
| MACD(12,26) | -0.0373 | Sell |
| ADX(14) | 31.13 | Sell |
| William %R | -85.80 | Buy |
| CCI(14) | -78.04 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2913
Sell
|
0.282
Sell
|
| MA20 |
0.3247
Sell
|
0.3133
Sell
|
| MA50 |
0.37
Sell
|
0.3711
Sell
|
| MA100 |
0.4872
Sell
|
0.4528
Sell
|
| MA200 |
0.5141
Sell
|
0.7171
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CGTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CGTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.5 indicates that CGTX is oversold. This indicates that CGTX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 20.05 indicates that CGTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.9126 indicates that CGTX is oversold. This suggests that CGTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.13 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -78.04 indicates that CGTX is still oversold but not to an extreme extent.
Long-term CGTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cognition Therapeutics Inc financial reports and earnings history, Cognition Therapeutics Inc (CGTX) stock could reach $1.6972 by 2030, $35.05 by 2040 and $18.16 by 2050. See the projected annual prices until 2050 of the Cognition Therapeutics Inc stock below:
- Cognition Therapeutics Inc (CGTX) is expected to reach an average price of $14.03 in 2035, with a high prediction of $14.81 and a low estimate of $14.07. This indicates an $5,772% rise from the last recorded price of $0.239.
- Cognition Therapeutics Inc (CGTX) stock is projected to chart a bullish course in 2040, with an average price target of $34.54, representing an $14,351% surge from its current level. The forecast ranges from a conservative $34.90 to a sky-high $35.05.
- Our analysts predict Cognition Therapeutics Inc (CGTX) to jump 26,549% by 2045, soaring from $64.14 to an average price of $63.69, potentially reaching $64.61. While $64.14 is the low estimate, the potential upside is significant.
- Cognition Therapeutics Inc (CGTX) stock is expected to climb by 2050, reaching an average of $16.94, a $6,989% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.16 and $16.97, respectively, highlighting the market's uncertainty.
Cognition Therapeutics Inc Stock (CGTX) Year by Year Forecast
Cognition Therapeutics Inc Stock (CGTX) Price Forecast for 2025
Cognition Therapeutics Inc Stock (CGTX) is expected to reach an average price of $4.738 in 2025, with a high prediction of $5.9829 and a low estimate of $3.4932. This indicates an +1,882% rise from the last recorded price of $0.239.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $2.9605 | $4.0805 | $5.0068 | +1,139% |
| August, 2025 | $3.8855 | $3.8942 | $3.5655 | +1,526% |
| September, 2025 | $3.9906 | $4.0406 | $3.743 | +1,570% |
| October, 2025 | $3.9393 | $3.9656 | $3.8531 | +1,548% |
| November, 2025 | $3.8344 | $3.8644 | $3.8869 | +1,504% |
| December, 2025 | $3.4532 | $3.4932 | $3.5281 | +1,345% |
Cognition Therapeutics Inc Stock (CGTX) Price Forecast for 2026
The predicted value for Cognition Therapeutics Inc (CGTX) in 2026 is set at an average of $1.8221. Estimates vary from a peak of $3.3469 to a trough of $0.2973, indicating an +662.39% surge from the present price of $0.239.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.4082 | $3.4607 | $3.3469 | +1,326% |
| February, 2026 | $1.9932 | $2.6632 | $2.7395 | +733.98% |
| March, 2026 | $2.7283 | $1.9857 | $1.5783 | +1,042% |
| April, 2026 | $2.617 | $2.617 | $2.642 | +995.00% |
| May, 2026 | $2.5021 | $2.5646 | $2.4814 | +946.89% |
| June, 2026 | $2.5671 | $2.4233 | $2.3958 | +974.10% |
| July, 2026 | $2.2559 | $2.3984 | $2.3296 | +843.89% |
| August, 2026 | $2.2559 | $2.3672 | $2.2572 | +843.90% |
| September, 2026 | $1.3797 | $1.8697 | $2.1547 | +477.28% |
| October, 2026 | $0.8847 | $0.9947 | $0.8441 | +270.18% |
| November, 2026 | $0.3198 | $0.3398 | $0.6203 | +33.80% |
| December, 2026 | $0.2386 | $0.2973 | $0.3148 | -0.18% |
Cognition Therapeutics Inc Stock (CGTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cognition Therapeutics Inc (CGTX) is $7.5051, with a high forecast of $15.01 and a low forecast of $0.00238. This indicates an +3,040% increase from the last price of $0.239.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2736 | $0.2723 | $0.1423 | +14.47% |
| February, 2027 | $0.0186 | $0.0149 | $0.245 | -92.21% |
| March, 2027 | $8.2875 | $0.00238 | $7.17 | +3,368% |
| April, 2027 | $11.27 | $10.28 | $10.53 | +4,614% |
| May, 2027 | $12.81 | $11.76 | $12.81 | +5,259% |
| June, 2027 | $14.17 | $13.35 | $14.36 | +5,827% |
| July, 2027 | $15.22 | $14.41 | $14.83 | +6,266% |
| August, 2027 | $14.68 | $15.22 | $15.01 | +6,040% |
| September, 2027 | $14.20 | $14.49 | $14.42 | +5,843% |
| October, 2027 | $13.73 | $14.18 | $13.69 | +5,646% |
| November, 2027 | $13.71 | $13.72 | $13.63 | +5,638% |
| December, 2027 | $13.39 | $13.49 | $13.92 | +5,503% |
Cognition Therapeutics Inc Stock (CGTX) Price Forecast for 2028
In 2028, Cognition Therapeutics Inc (CGTX) is projected to reach an average price of $10.45, with a high projection of $12.93 and a low estimate of $7.9713. This indicates an +4,272% rise from the last price of $0.239.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.30 | $13.41 | $12.93 | +5,465% |
| February, 2028 | $12.68 | $12.75 | $12.52 | +5,206% |
| March, 2028 | $12.51 | $12.52 | $12.56 | +5,134% |
| April, 2028 | $12.02 | $12.06 | $11.95 | +4,929% |
| May, 2028 | $11.70 | $11.69 | $11.67 | +4,794% |
| June, 2028 | $9.946 | $10.31 | $10.47 | +4,062% |
| July, 2028 | $10.01 | $10.22 | $9.8761 | +4,087% |
| August, 2028 | $9.5837 | $9.8637 | $9.7611 | +3,910% |
| September, 2028 | $9.6537 | $9.7387 | $9.5287 | +3,939% |
| October, 2028 | $8.8638 | $9.149 | $9.3913 | +3,609% |
| November, 2028 | $8.4614 | $8.5814 | $8.5763 | +3,440% |
| December, 2028 | $7.7214 | $7.9713 | $8.3532 | +3,131% |
Cognition Therapeutics Inc Stock (CGTX) Price Forecast for 2029
The 2029 price forecast for Cognition Therapeutics Inc Stock (CGTX) is $4.8656 on average, with a high prediction of $7.5789 and a low estimate of $2.1522. This represents an +1,936% increase from the previous price of $0.239.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.479 | $6.619 | $7.5789 | +2,611% |
| February, 2029 | $6.8891 | $7.0728 | $7.144 | +2,782% |
| March, 2029 | $6.7291 | $6.7291 | $6.7941 | +2,716% |
| April, 2029 | $6.3192 | $6.4006 | $6.5897 | +2,544% |
| May, 2029 | $6.0268 | $6.0568 | $6.1567 | +2,422% |
| June, 2029 | $5.7468 | $5.8068 | $5.7743 | +2,305% |
| July, 2029 | $5.4069 | $5.5168 | $5.6343 | +2,162% |
| August, 2029 | $4.1545 | $4.3545 | $5.1144 | +1,638% |
| September, 2029 | $3.1045 | $3.4457 | $3.7151 | +1,199% |
| October, 2029 | $2.8821 | $2.7746 | $2.7131 | +1,106% |
| November, 2029 | $2.4222 | $2.4922 | $2.6796 | +913.45% |
| December, 2029 | $1.8922 | $2.1522 | $2.2297 | +691.72% |
Cognition Therapeutics Inc Stock (CGTX) Price Forecast for 2030
Cognition Therapeutics Inc Stock (CGTX) is expected to reach an average price of $12.69 in 2030, with a high forecast of $23.90 and a low forecast of $1.4798. This signifies an +5,209% surge from the last price of $0.239.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5885 | $1.4798 | $1.6972 | +564.65% |
| February, 2030 | $20.78 | $18.21 | $18.71 | +8,596% |
| March, 2030 | $23.78 | $21.49 | $21.08 | +9,849% |
| April, 2030 | $22.10 | $22.80 | $22.43 | +9,149% |
| May, 2030 | $23.50 | $23.64 | $23.70 | +9,733% |
| June, 2030 | $24.33 | $24.09 | $23.88 | +10,078% |
| July, 2030 | $23.39 | $23.49 | $23.90 | +9,687% |
| August, 2030 | $22.55 | $22.67 | $22.35 | +9,334% |
| September, 2030 | $21.96 | $22.13 | $22.02 | +9,089% |
| October, 2030 | $21.96 | $21.87 | $21.85 | +9,088% |
| November, 2030 | $21.11 | $21.17 | $21.33 | +8,734% |
| December, 2030 | $20.19 | $20.23 | $20.50 | +8,347% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):